Although whole-exome sequencing (WES) is the gold standard for the diagnosis of neurodevelopmental disorders (NDDs), it remains expensive for some genetic centers. Commercialized panels comprising all OMIM-referenced genes called "medical exome" (ME) constitute an alternative strategy to WES, but its efficiency is poorly known. In this study, we report the experience of 2 clinical genetic centers using ME for diagnosis of NDDs. We recruited 216 consecutive index patients with NDDs in 2 French genetic centers, corresponded to the daily practice of the units and included non-syndromic intellectual disability (NSID, n = 33), syndromic ID (NSID = 122), pediatric neurodegenerative disorders (n = 7) and autism spectrum disorder (ASD, n = 54). We sequenced samples from probands and their parents (when available) with the Illumina TruSight One sequencing kit. We found pathogenic or likely pathogenic variants in 56 index patients, for a global diagnostic yield of 25.9%. The diagnosis yield was higher in patients with ID as the main diagnosis (32%) than in patients with ASD (3.7%). Our results suggest that the use of ME is a valuable strategy for patients with ID when WES cannot be used as a routine diagnosis tool.
Exome Sequencing , Genetic Association Studies , Genetic Predisposition to Disease , Neurodevelopmental Disorders/genetics , Adolescent , Adult , Alleles , Child , Child, Preschool , Computational Biology/methods , Female , Genetic Association Studies/methods , Humans , Infant , Inheritance Patterns , Male , Middle Aged , Neurodevelopmental Disorders/diagnosis , Phenotype , Sequence Analysis, DNA/methods , Young Adult
The striking excess of affected males in autism spectrum disorders (ASD) suggests that genes located on chromosome X contribute to the etiology of these disorders. To identify new X-linked genes associated with ASD, we analyzed the entire chromosome X exome by next-generation sequencing in 12 unrelated families with two affected males. Thirty-six possibly deleterious variants in 33 candidate genes were found, including PHF8 and HUWE1, previously implicated in intellectual disability (ID). A nonsense mutation in TMLHE, which encodes the É-N-trimethyllysine hydroxylase catalyzing the first step of carnitine biosynthesis, was identified in two brothers with autism and ID. By screening the TMLHE coding sequence in 501 male patients with ASD, we identified two additional missense substitutions not found in controls and not reported in databases. Functional analyses confirmed that the mutations were associated with a loss-of-function and led to an increase in trimethyllysine, the precursor of carnitine biosynthesis, in the plasma of patients. This study supports the hypothesis that rare variants on the X chromosome are involved in the etiology of ASD and contribute to the sex-ratio disequilibrium.
Child Development Disorders, Pervasive/genetics , Chromosomes, Human, X/genetics , Genes, X-Linked , Mixed Function Oxygenases/genetics , Adult , Case-Control Studies , Child , Cohort Studies , Exome , Family , Female , Genetic Association Studies , Humans , Male , Mutation , Polymerase Chain Reaction , Sex Distribution
Autistic Disorder/epidemiology , Epilepsy/epidemiology , Adolescent , Adult , Autistic Disorder/psychology , Autistic Disorder/therapy , Brain Damage, Chronic/epidemiology , Child , Child, Preschool , Comorbidity , Cross-Sectional Studies , Epilepsy/psychology , Epilepsy/therapy , Female , Humans , Intellectual Disability/epidemiology , Intellectual Disability/psychology , Intellectual Disability/therapy , Male , Neurologic Examination , Prognosis , Young Adult
